# US 2019/0184062 A1 · Reinforced biologic material

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0184062 A1
- Document ID: US20190184062A1
- Status: Published application
- Kind: A1
- Application number: 16/227,814
- Filed: 2018-12-20
- Published: 2019-06-20
- Earliest claimed: 2008-11-21
- Assignees: LifeCell Corporation
- Applicants: LifeCell Corporation
- Inventors: Sangwook Park; Aaron Barere; Christopher T. Wagner; Robert Kiefer; E. Skott Greenhalgh
- Web page: https://patentgrep.com/patent/US20190184062A1

## CPC

- A61L 27/44: having a macromolecular matrix
- A61L 27/3604: {characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel}
- A61L 27/3691: {characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation}
- A61L 27/427: {of other specific inorganic materials not covered by A61L27/422 or A61L27/425}
- A61L 27/446: {with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46}
- A61L 27/48: with macromolecular fillers
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- B29C 63/06: around tubular articles
- A61F 2/08: Muscles; Tendons; Ligaments
- A61L 2430/10: for reconstruction of tendons or ligaments
- A61L 2430/34: for soft tissue reconstruction
- B29C 63/341: {pressed against the wall by mechanical means}
- B29C 2053/8025: {tensioning}
- B29K 2305/00: Use of metals, their alloys or their compounds, as reinforcement
- B29K 2905/14: Noble metals, e.g. silver, gold or platinum
- B29K 2995/006: Bio-degradable, e.g. bioabsorbable, bioresorbable or bioerodible
- B29L 2031/753: {Medical equipment; Accessories therefor (bloodbags, medical bags B29L2031/7148; artificial eyes B29L2011/0008)}
- B29L 2031/7532: {Artificial members, protheses}
- Y10T 29/49826: Assembling or joining
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- B29C: SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING (making preforms B29B11/00; making laminated products by combining previously unconnected layers which become one product whose layers will remain together B32B37/00 - B32B41/00)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- B29K: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR {MOULDS, } REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29L: INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The present disclosure provides an implantable medical device comprising a composite graft material including a first biologic component, such as an acellular tissue matrix, and a second non-biologic component.

## Claims

### Claim 1

An implantable medical device, comprising:
a group of first elongate non-biologic elements;
a sheath wrapped around and surrounding at least a portion of the group of first elongate non-biologic elements; and
at least one second elongate non-biologic element, wherein the at least one second element secures at least one end portion of the group of first elongate non-biologic elements.

### Claim 2 (depends on 1)

The implantable medical device of claim 1, wherein at least a portion of the group of first elongate non-biologic elements are under a tensile or compressive stress prior to implantation.

### Claim 3 (depends on 2)

The implantable medical device of claim 2, wherein at least a portion of the group of first elongate non-biologic elements are loaded with the tensile or compressive stress independently of the sheath.

### Claim 4 (depends on 1)

The implantable medical device of claim 1, wherein at least a portion of the group of first elongate non-biologic elements and the sheath are loaded together with a tensile or compressive stress.

### Claim 5 (depends on 2)

The implantable medical device of claim 2, wherein the group of first elongate non-biologic elements have a higher load capacity than the sheath at the time of implantation.

### Claim 6 (depends on 5)

The implantable medical device of claim 5, wherein the sheath has a higher load capacity than the group of first elongate non-biologic elements after implantation and following growth of native cells within the sheath.

### Claim 7 (depends on 1)

The implantable medical device of claim 1, wherein the sheath comprises a non-biologic material.

### Claim 8 (depends on 1)

The implantable medical device of claim 1, wherein the sheath comprises a biologic component including a biomatrix.

### Claim 9 (depends on 8)

The implantable medical device of claim 8, wherein the biomatrix comprises an acellular tissue matrix or a particulate acellular tissue matrix.

### Claim 10 (depends on 1)

The implantable medical device of claim 1, wherein the at least one second elongated non-biologic element is wrapped around and over the sheath to secure at least one end portion of the group of first elongate non-biologic elements.

### Claim 11 (depends on 1)

The implantable medical device of claim 1, wherein the sheath forms a single layer over the group of first elongate non-biologic elements.

### Claim 12 (depends on 1)

The implantable medical device of claim 1, wherein the sheath is wrapped in a jellyroll fashion with multiple layers over the group of first elongate non-biologic elements.

### Claim 13 (depends on 1)

The implantable medical device of claim 1, wherein the sheath is wrapped in a non-uniform jellyroll fashion with multiple non-concentric layers over the group of first elongate non-biologic elements.

### Claim 14 (depends on 1)

The implantable medical device of claim 1, comprising an outer sheath wrapped around and surrounding at least a portion of the sheath.

### Claim 15 (depends on 1)

The implantable medical device of claim 1, wherein the group of first elongate non-biologic elements comprise at least one material chosen from bioabsorbable polymer, bioabsorbable metal, or a combination of bioabsorbable polymer and bioabsorbable metal.

### Claim 16 (depends on 1)

The implantable medical device of claim 1, wherein the group of first elongate non-biologic elements comprise at least one material chosen from polyhydroxyalkanoate, poly-hydroxybutyrate, polylactic acid (PLA), polyglycolic acid (PGA), polylactideglycolide acid (PLGA), polydioxanone (PDO), polycaprolactone (PCL), a polyanhydride, a polyorthoester, a poly(amino acid), a polypeptide, a polydepsipeptide, a nylon-2/nylon-6 copolyamide, a poly(alkylene succinate), poly(hydroxyl butyrate) (PHB), poly(butylene diglocolate), poly(.epsilon.-caprolactone), a polydihydropyran, a polyphosphazene, a poly(cyano acrylates), modified polysaccharides, cellulose, starch, chitin, modified proteins, collagen, fibrin, and combinations and copolymers thereof.

### Claim 17 (depends on 1)

The implantable medical device of claim 1, wherein the group of first elongate non-biologic elements comprise a bioabsorbable polymer, a bioabsorbable metal or a combination of a bioabsorbable polymer and bioabsorbable metal.

### Claim 18 (depends on 2)

The implantable medical device of claim 2, wherein the group of first elongate non-biologic elements are under a tensile stress ranging from greater than 0 N to about 1800 N.

### Claim 19 (depends on 1)

The implantable medical device of claim 1, wherein the group of first elongate non-biologic elements comprise a plurality of threads, cords, cables, ribbons, or braids.

### Claim 20

An implantable medical device, comprising:
a group of first elongate non-biologic elements, at least a portion of which are under a tensile or compressive stress prior to implantation;
a sheath wrapped around and surrounding at least a portion of the group of first elongate non-biologic elements; and
at least one second elongate non-biologic element, wherein the at least one second element secures at least one end portion of the group of first elongate non-biologic elements;
wherein the group of first elongate non-biologic elements have a higher load capacity than the sheath at the time of implantation; and
wherein the sheath has a higher load capacity than the group of first elongate non-biologic elements after implantation and following growth of native cells within the sheath.
